Target intelligence / Profile preview

Aluminum(III) trifluoromethanesulfonate (Al(OTf)3)

Target
Al(OTf)3
Molecular classification
Lewis acid, Catalyst, Inorganic salt
01

Overview

Aluminum triflate, or aluminum(III) trifluoromethanesulfonate, is a powerful and versatile Lewis acid catalyst widely employed in synthetic organic chemistry. It is characterized by its high stability, water tolerance, and recyclability, making it an environmentally friendly alternative to traditional Lewis acids like aluminum trichloride. The compound facilitates a broad range of chemical transformations, including Friedel-Crafts reactions, Michael additions, and the amination of alcohols. While it is not a biological target or a therapeutic agent, it is instrumental in the synthesis of various pharmaceuticals, such as the aromatase inhibitor letrozole. Its primary mode of action involves the coordination of the aluminum center to nucleophilic sites on substrates, thereby activating them for subsequent chemical reactions. In the context of human health, the aluminum(III) ion is primarily associated with toxicity and is managed via chelation therapy using agents like deferoxamine. Aluminum triflate itself is typically handled as a laboratory reagent and is not found naturally in biological systems. Its significance in medicinal chemistry lies in its utility for constructing complex molecular architectures efficiently. Safety concerns regarding the molecule include its corrosive nature and the potential for systemic aluminum accumulation if exposure occurs. Overall, it is a critical tool for chemists but does not serve as a direct site for drug action in a therapeutic sense.

Other names
Aluminum triflateTrifluoromethanesulfonic acid aluminum saltTriflic acid aluminum saltAluminum(3+) triflate
02

Mechanism of action

Chelation of the aluminum(III) ion to facilitate its excretion from the body.

03

Biological functions

None
04

Disease associations

Aluminum toxicity
05

Safety considerations

CorrosiveCauses severe skin burns and eye damagePotential neurotoxicity upon chronic exposure to aluminum ionsBone toxicity (osteomalacia)
06

Interacting drugs

Deferoxamine

2 more in the full profile.

07

Biomarkers

Serum aluminum levels

Beyond the preview

Go deeper on Aluminum(III) trifluoromethanesulfonate (Al(OTf)3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aluminum(III) trifluoromethanesulfonate (Al(OTf)3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call